Secondary electrospray ionization-mass spectrometry (SESI-MS) breathprinting of multiple Bacterial lung pathogens, a mouse model study

Journal of Applied Physiology

Volumn 114, Issue 11, 2013, Pages 1544-1549

  Zhu, Jiangjiang ^a   Bean, Heather D ^a   Jiménez Díaz, Jaime ^a   Hill, Jane E ^a  

^a University of Vermont   (United States)

Author keywords

Bacteria; Breath analysis; Lung infection; SESI MS; VOC

Indexed keywords

ANIMAL; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM; BACTERIUM IDENTIFICATION; BREATH ANALYSIS; C57BL MOUSE; ELECTROSPRAY MASS SPECTROMETRY; ISOLATION AND PURIFICATION; LUNG INFECTION; MALE; METHODOLOGY; MICROBIOLOGY; MOUSE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SESI-MS; VOC;

BACTERIA; BREATH ANALYSIS; LUNG INFECTION; SESI-MS; VOC;

ANIMALS; BACTERIA; BACTERIAL TYPING TECHNIQUES; BREATH TESTS; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA, BACTERIAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84878531072     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00099.2013     Document Type: Article

References (51)

1. Allard JB, Rinaldi L, Wargo MJ, Allen G, Akira S, Uematsu S, Poynter ME, Hogan DA, Rincon M, Whittaker LA. Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products. Eur J Immunol 39:776-788, 2009.
2. Anevlavis S, Bouros D. Community acquired bacterial pneumonia. Expert Opin Pharmacother 11:361-374, 2010.
3. Bean HD, Zhu J, Hill JE. Characterizing bacterial volatiles using secondary electrospray ionization mass spectrometry (SESI-MS). J Vis Exp 52 (Online). http://www.jove.com/details.php7id=2664 [accessed Nov. 1, 2012].
4. Becker PD, Bertot GM, Souss D, Ebensen T, Guzman CA, Grinstein S. Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model. Infect Immun 75:1778-1784, 2007. (Pubitemid 46559445)
5. Broug-Holub E, Toews GB, Van Iwaarden JF, Strieter RM, Kunkel L, Paine R 3rd, Standiford TJ. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect Immun 65:1139-1146, 1997. (Pubitemid 27146594)
6. Bunge M, Araghipour N, Mikoviny T, Dunkl J, Schnitzhofer R, Hansel A, Schinner F, Wisthaler A, Margesin R, Mark TD. On-line monitoring of microbial volatile metabolites by proton transfer reactionmass spectrometry. Appl Environ Microbiol 74:2179-2186, 2008. (Pubitemid 351522073)
7. Carroll W, Lenney W, Wang TS, Ŝpanêl P, Alcock A, Smith D. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol 39:452-456, 2005. (Pubitemid 40548288)
8. Chambers ST, Syhre M, Murdoch DR, McCartin F, Epton MJ. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med Mycol 47:468-476, 2009.
9. Cristoni S, Molin L, Lai A, Bernardi LR, Pucciarelli S, Agostini M, Bedin C, Nitti D, Seraglia R, Repetto O, Dibari VF, Orlandi R, Sinues PM, Traldi P. Maldi-MS-NIST library approach for colorectal cancer diagnosis. Rapid Commun Mass Spectrom 23:2839-2845, 2009.
10. Esposito S, Principi N. Unsolved problems in the approach to pediatric community-acquired pneumonia. Curr Opin Infect Dis 25:286-291, 2012.
11. Essilfie AT, Simpson JL, Horvat JC, Preston JA, Dunkley ML, Foster PS, Gibson PG, Hansbro PM. Haemophilus influenzae infection drives IL-17-mediated neutrophilic allergic airways disease. PLoS Pathog 7:e1002244, 2011.
12. Forsgren A, Brant M, Riesbeck K. Immunization with the truncated adhesin Moraxella catarrhalis immunoglobulin D-binding protein (MID764-913) is protective against M. catarrhalis in a mouse model of pulmonary clearance. J Infect Dis 190:352-355, 2004. (Pubitemid 38951977)
13. Frutuoso MS, Hori JI, Pereira MS, Junior DS, Sonego F, Kobayashi KS, Flavell RA, Cunha FQ, Zamboni DS. The pattern recognition receptors NOD1 and NOD2 account for neutrophil recruitment to the lungs of mice infected with Legionella pneumophila. Microbes Infect 12:819-827, 2010.
14. Gentile A, Bardach A, Ciapponi A, Garcia-Marti S, Aruj P, Glujovsky D, Calcagno JI, Mazzoni A, Colindres RE. Epidemiology of community-acquired pneumonia in children of Latin America and the Caribbean: a systematic review and meta-analysis. Int J Infect Dis 16:e5-e15, 2012.
15. Gilchrist FJ, Razavi C, Webb AK, Jones AM, Ŝpanêl P, Smith D, Lenney W. An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide. J Breath Res 6:036004, 2012.
16. Herrero FS, Olivas JB. Microbiology and risk factors for communityacquired pneumonia. Semin Respir Crit Care Med 33:220-231, 2012.
17. Hockstein NG, Thaler ER, Torigian D, Miller WT, Deffenderfer O, Hanson CW. Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope 114:1701-1705, 2004. (Pubitemid 39332240)
18. Hockstein NG, Thaler ER, Yuanqing L, Lee DD, Hanson CW. Correlation of pneumonia score with electronic nose signature: a prospective study. Ann Otol Rhinol Laryngol 114:504-508, 2005. (Pubitemid 40995032)
19. Hoogendijk AJ, Diks SH, Peppelenbosch MP, Van der Poll T, Wieland CW. Kinase activity profiling of Gram-negative pneumonia. Mol Med 17:741-747, 2011.
20. Hunter JD. Ventilator associated pneumonia. Postgrad Med J 82:172-178, 2006.
21. Kapetanovic R, Jouvion G, Fitting C, Parlato M, Blanchet C, Huerre M, Cavaillon JM, Adib-Conquy M. Contribution of NOD2 to lung inflammation during Staphylococcus aureus-induced pneumonia. Microbes Infect 12:759-767, 2010.
22. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, Cardo DM. Estimating health care-associated infections and deaths in U. S. hospitals, 2002. Public Health Rep 122:160-166, 2007.
23. Kyd JM, Cripps AW, Murphy TF. Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance. J Med Microb 47:159-168, 1998. (Pubitemid 28041260)
24. Li GQ, Bai XG, Li CR, Yang XY, Hu XX, Yuan M, Zhang WX, Lou RH, Guo HY, Jiang JD, You XF. In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic. J Antimicrob Chemother 67:955-961, 2012.
25. Lung ML, Codina G. Molecular diagnosis in HAP/VAP. Curr Opin Crit Care 18:487-494, 2012.
26. Martinez-Lozano P, de la Mora J. Electrospray ionization of volatiles in breath. Int J Mass Spectrom 265:68-72, 2007.
27. Martinez-Lozano P, de la Mora J. On-line detection of human skin vapors. J Am Soc Mass Spectrom 20:1060-1063, 2009.
28. Martinez-Lozano P, Zingaro L, Finiguerra A, Cristoni S. Secondary electrospray ionization-mass spectrometry: breath study on a control group. J Breath Res 5:2011.
29. Mathers C, Boerma T, Fat DM. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization, 2008.
30. Neuhaus S, Seifert L, Vautz W, Nolte J, Bufe A, Peters M. Comparison of metabolites in exhaled breath and bronchoalveolar lavage fluid samples in a mouse model of asthma. J Appl Physiol 111:1088-1095, 2011.
31. Phillips M, Basa-Dalay V, Bothamley G, Cataneo RN, Lam PK, Natividad MP, Schmitt P, Wai J. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis 90:145-151, 2010.
32. Phillips M, Cataneo RN, Condos R, Erickson GA, Greenberg J, La Bombardi V, Munawar MI, Tietje O. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis 87:44-52, 2007. (Pubitemid 44960164)
33. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 729:75-88, 1999. (Pubitemid 29264111)
34. Prayle A, Atkinson M, Smyth A. Pneumonia in the developed world. Paediatr Respir Rev 12:60-69, 2011.
35. Razavi HM. Pulmonary neutrophil infiltration in murine sepsis: role of inducible nitric oxide synthase. Am J Respir Crit Care Med 170:227-233, 2004. (Pubitemid 38971406)
36. Rello J. Bench-to-bedside review: therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care 9:259-265, 2005. (Pubitemid 40796803)
37. Robroeks CM, van Berkel JJ, Dallinga JW, Jobsis Q, Zimmermann LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 68:75-80, 2010.
38. Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH, Zerrahn J. Comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology 120:380-391, 2007. (Pubitemid 46232913)
39. Roy CR, Fontana MF, Banga S, Barry KC, Shen X, Tan Y, Luo ZQ, Vance RE. Secreted bacterial effectors that inhibit host protein synthesis are critical for induction of the innate immune response to virulent Legionella pneumophila. PLoS Pathog 7:e1001289, 2011.
40. Scott-Thomas A, Syhre M, Pattemore P, Epton M, Laing R, Pearson J, Chambers S. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulm Med 10:56, 2010.
41. Scott RD, II. The direct medical costs of healthcare-associated infections in U. S. hospitals and the benefits of prevention. Atlanta: Centers for Disease Control and Prevention, 2009.
42. Sinues PM, Alonso-Salces RM, Zingaro L, Finiguerra A, Holland MV, Guillou C, Cristoni S. Mass spectrometry fingerprinting coupled to National Institute of Standards and Technology Mass Spectral search algorithm for pattern recognition. Anal Chim Acta 755:28-36, 2012.
43. Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST. The scent of Mycobacterium tuberculosis-part II breath. Tuberculosis 89:263-266, 2009.
44. Vautz W, Nolte J, Bufe A, Baumbach JI, Peters M. Analyses of mouse breath with ion mobility spectrometry: a feasibility study. J Appl Physiol 108:697-704, 2010.
45. Vijeyaratnam GS, Corrin B. Pulmonary histiocytosis simulating desquamative interstitial pneumonia in rats receiving oral iprindole. JPathol 108:105-113, 1972.
46. + with compounds released by Pseudomonas and related bacteria. Int J Mass Spectrom 233:245-251, 2004.
47. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, Weiser JN, Wilson JM. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J Immunol 168:810-815, 2002. (Pubitemid 34049582)
48. Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, Allen GB, Vasil ML, Leclair LW, Hogan DA. Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 184:345-354, 2011.
49. Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 67:71-79, 2012.
50. Zhu J, Bean HD, Kuo YM, Hill JE. Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionizationmass spectrometry. J Clin Microbiol 48:4426-4431, 2010.
51. Zhu J, Bean HD, Wargo MJ, Leclair LW, Hill JE. Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints. J Breath Res 7:016003, 2013.